| Dr Daniel S Loo, MD | |
|
31 Roche Bros Way, Suite 200, North Easton, MA 02356-1032 | |
| (508) 535-3376 | |
| (508) 535-3377 |
| Full Name | Dr Daniel S Loo |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 31 Years |
| Location | 31 Roche Bros Way, North Easton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982695573 | NPI | - | NPPES |
| 3198421 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 161035 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Signature Healthcare Brockton Hospital | Brockton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Shore Dermatology Physicians Pc | 4789767104 | 11 |
News Archive
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
Macada Holding, Inc. (PINKSHEETS: MCDA) announces its subsidiary LyfeTec, Inc. has signed an exclusive territory agreement for the Central Republic of Africa with the company K-World trade with Prince Ketcha whose company specializes in all medical equipment/supplies with and for government support in Douala, Cameroon, Africa.
Researchers at Aalto University have developed a simple method for reducing the amount of phosphorus in the wastewater of a pulp mill. The method is called simultaneous precipitation using iron sulphate. A separate treatment stage is not required, as the precipitation takes place simultaneously with the actual biological wastewater treatment.
GenVec, Inc. (Nasdaq: GNVC) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 8,000,000 shares of its common stock and warrants to purchase 4,000,000 shares of its common stock. The shares of common stock and warrants are being offered in units consisting of one share of common stock and 0.50 warrants to purchase one share of common stock at a price of $0.75 per unit. This represents a discount of approximately 8.3% to the closing price of GenVec common stock on August 26, 2009. The warrants have a term of five years and an exercise price of $0.828 per share.
› Verified 1 days ago
| Entity Name | South Shore Dermatology Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992988703 PECOS PAC ID: 4789767104 Enrollment ID: O20080208000161 |
News Archive
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
Macada Holding, Inc. (PINKSHEETS: MCDA) announces its subsidiary LyfeTec, Inc. has signed an exclusive territory agreement for the Central Republic of Africa with the company K-World trade with Prince Ketcha whose company specializes in all medical equipment/supplies with and for government support in Douala, Cameroon, Africa.
Researchers at Aalto University have developed a simple method for reducing the amount of phosphorus in the wastewater of a pulp mill. The method is called simultaneous precipitation using iron sulphate. A separate treatment stage is not required, as the precipitation takes place simultaneously with the actual biological wastewater treatment.
GenVec, Inc. (Nasdaq: GNVC) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 8,000,000 shares of its common stock and warrants to purchase 4,000,000 shares of its common stock. The shares of common stock and warrants are being offered in units consisting of one share of common stock and 0.50 warrants to purchase one share of common stock at a price of $0.75 per unit. This represents a discount of approximately 8.3% to the closing price of GenVec common stock on August 26, 2009. The warrants have a term of five years and an exercise price of $0.828 per share.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel S Loo, MD 31 Roche Bros Way, Suite 200, North Easton, MA 02356-1032 Ph: (508) 535-3376 | Dr Daniel S Loo, MD 31 Roche Bros Way, Suite 200, North Easton, MA 02356-1032 Ph: (508) 535-3376 |
News Archive
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
Macada Holding, Inc. (PINKSHEETS: MCDA) announces its subsidiary LyfeTec, Inc. has signed an exclusive territory agreement for the Central Republic of Africa with the company K-World trade with Prince Ketcha whose company specializes in all medical equipment/supplies with and for government support in Douala, Cameroon, Africa.
Researchers at Aalto University have developed a simple method for reducing the amount of phosphorus in the wastewater of a pulp mill. The method is called simultaneous precipitation using iron sulphate. A separate treatment stage is not required, as the precipitation takes place simultaneously with the actual biological wastewater treatment.
GenVec, Inc. (Nasdaq: GNVC) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 8,000,000 shares of its common stock and warrants to purchase 4,000,000 shares of its common stock. The shares of common stock and warrants are being offered in units consisting of one share of common stock and 0.50 warrants to purchase one share of common stock at a price of $0.75 per unit. This represents a discount of approximately 8.3% to the closing price of GenVec common stock on August 26, 2009. The warrants have a term of five years and an exercise price of $0.828 per share.
› Verified 1 days ago
Amy S Chang, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Lindsay Eminger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Jay M Ritt, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Viraj O Shroff-mehta, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Dr. Kyung Hee Chang, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Brothers Way Ste 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Dr. Christine Urman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 | |
Leera M Briceno, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 31 Roche Bros Way, Suite 200, North Easton, MA 02356 Phone: 508-535-3376 Fax: 508-535-3377 |